BridgeMD
New treatment option for ACL Injury
Official title The Pediatric ALL Evaluation and Trial
ClinicalTrials.gov ID: NCT04825587
What this study is testing
- What it's testing
- The overall aim of this multicenter RCT is to determine whether concomitant ALL reconstruction in children undergoing and ACL reconstruction will longitudinally result in a lower rate of graft failure than ACL reconstruction alone.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 18. Healthy volunteers may be eligible.
You may be able to join if
- Age 18 and under
- Surgery within 6 months of injury
- Undergoing primary ACL reconstruction without previous injury or surgery
- Quadriceps tendon autograft ACL reconstruction
- Closing or closed physes
You likely can't join if
- Over 18 years old
- Previous ipsilateral knee injury or surgery
- Neuromuscular or developmental disorders affecting knee anatomy, cognition, or neuromuscular control
- Other concomitant ligament reconstruction aside from the ALL (i.e., MCL, PCL, PLC)
- Revision ACL reconstruction
- ACL reconstruction with graft other than quadriceps tendon
See the full eligibility criteria
- Age 18 and under
- Surgery within 6 months of injury
- Undergoing primary ACL reconstruction without previous injury or surgery
- Quadriceps tendon autograft ACL reconstruction
- Closing or closed physes
- Over 18 years old
- Previous ipsilateral knee injury or surgery
- Neuromuscular or developmental disorders affecting knee anatomy, cognition, or neuromuscular control
- Other concomitant ligament reconstruction aside from the ALL (i.e., MCL, PCL, PLC)
- Revision ACL reconstruction
- ACL reconstruction with graft other than quadriceps tendon
- IT band (modified MacIntosh) ACL reconstruction
- A cartilage lesion requiring anything more than debridement
- Open physes requiring both femoral and tibial physeal-sparing technique
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 18 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.